Alkermes plc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Alkermes plc. payments for repurchase of common stock for the quarter ending 2026-06-30 was $0.00.
- Alkermes plc. payments for repurchase of common stock for the quarter ending 2026-03-31 was $27.70M.
- Alkermes plc. payments for repurchase of common stock for the quarter ending 2024-12-31 was $1.00K.
- Alkermes plc. payments for repurchase of common stock for the quarter ending 2024-09-30 was $115.59M.
- Alkermes plc. payments for repurchase of common stock for fiscal 2024 was $200.28M.
- Alkermes plc. payments for repurchase of common stock for fiscal 2010 was $2.68M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | |
| 2026-03-31 | $27.70M 10-Q · filed 2026-05-05 | |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $200.28M 10-K · filed 2026-02-25 |
| 2024-09-30 | $115.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | |
| 2010-03-31 | $2.68M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |